<DOC>
	<DOCNO>NCT02355990</DOCNO>
	<brief_summary>The study objective demonstrate safety Minimally Invasive Micro Sclerostomy ( MIMS ) device lower elevate IOP patient diagnose glaucoma .</brief_summary>
	<brief_title>Minimally Invasive Micro Sclerostomy First Man Safety Preliminary Performance Study</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>End Stage primary openangle glaucoma , pseudoexfoliation glaucoma pigmentary glaucoma study eye ( EGS criterion ) Optic nerve appearance characteristic glaucoma study eye Bestcorrected visual acuity ( BCVA ) countingfingers , hand movement , light perception light perception due glaucomatous loss central vision study eye Patient treat 1 5 hypotensive medication study eye Unsatisfactory medicate IOP ( ≥ 18 mmHg ) screen visit study eye Shaffer grade ≥ III four angle quadrant study eye Subject able willing attend schedule followup exam Subject understands sign inform consent Subjects present 1 follow criterion enrol trial : Ocular condition poorer prognosis fellow eye study eye Closed angle form glaucoma either eye Congenital developmental glaucoma either eye Other secondary glaucoma ( neovascular , uveitic , lensinduced , traumainduced , glaucoma associate increased episcleral venous pressure ) study eye Peripheral anterior synechiae ( PAS ) , rubeosis angle abnormality study eye Subject history penetrate keratoplasty ( PKP ) Any previous surgery study eye ( except clear corneal cataract surgery ) conjunctiva intact elastic . Any ocular disease history study eye severe dry eye , active proliferative retinopathy , ICE syndrome , epithelial fibrous growth , ocular pathology may interfere accurate IOP measurement Prior surgery abinterno abexterno device implant Schlemm 's canal study eye . Use oral hypotensive medication glaucoma treatment fellow eye Less minimum visual function require drive fellow eye : bestcorrected visual acuity bad 20/40 ( Snellen equivalent ) Esterman visual field score le 85 % . History idiopathic autoimmune uveitis either eye Severe trauma study eye active iris neovascularization , previous cyclodestructive procedure , prior scleral buckling procedure , presence silicone oil , need glaucoma surgery combine ocular procedure anticipate need additional ocular surgery study eye within 12 month period Vitreous present anterior chamber , prior vitrectomy virteous hemorrhage study eye Aphakia Prior vitreoretinal surgery study eye Clinically significant ocular inflammation infection within 90 day prior screen Unable discontinue use blood thinner accordance surgeon 's standard preoperative instruction Uncontrolled systemic disease opinion investigator would put subject 's health risk and/or prevent subject complete study visit Current participation participation another investigational drug device clinical trial within last 30 day screen visit Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>